Cronos Group Inc. Common Share (CRON)
Nasdaq · Common stock · Medicinal Chemicals & Botanical Products
As of Oct 21, 3:16 PM ET15 min delayedAbout 15 minutes behind the market. Every member plan is real time.
Follow CRON in real time
Real-time quotes, Pro Charting, the scanner and the alert feed on CRON and every other US listing.
Start 5 days freeTry Premium Membership free for 5 days. Card required. After 5 days it is $149 per month or $1,099 per year until you cancel. First-time members only.
CRON at a glance
Key statistics
$1.21B
Market capitalization
- Previous close
- $3.28
- Open
- $3.30
- Day range
- $3.27 – $3.45
- Volume
- 828.9K
- Average volume (30 sessions)
- 838.5K
- Shares outstanding
- 368.54M
- Price / earnings
- 17.3
- Earnings per share
- $0.19
- Price / book
- 1.1
- Price / sales
- 4.7
- Beta (1 year, vs SPY)
- 0.61
Where the price sits in its year
52-week range
83% of the range
- Below the 52-week high
- -6.2%
- Above the 52-week low
- +48.5%
Completed sessions through Oct 20, 2026
Technical snapshot
Above its 50-day and 200-day averages
- 20-day average
- $3.27+0.4%
- 50-day average
- $3.27+0.2%
- 200-day average
- $2.83+16.1%
Between the conventional 30 and 70 bands.
+2.5%
1 week
-1.5%
1 month
+18.0%
3 months
+24.7%
Year to date
+31.7%
1 year
Price change over each window, from completed sessions. Past performance does not indicate future results.
Every plan: MACD, ATR, the 20- and 50-day ranges, five-year and all-history extremes and the full indicator set, live on Pro Charting.The member platform, in real time
What members do with CRON
CRON on Pro Charting
Every intraday interval in real time, the drawing kit and the full set of technical studies on CRON.
See the plans →
Every planScreen names like CRON
The real-time scanner: price, volume, technical, fundamental and chart-pattern filters across the whole US market.
See the plans →
Analysis Tools OnlySet a price line on CRON
Put CRON on your watchlist, draw the levels you care about, and My Dashboard tracks where it trades against them.
See the plans →
Stock Alerts + ToolsOpen alerts on CRON
See whether there is an open premium alert on CRON, with its entry, stop and exit, each one reviewed by an analyst before it is sent.
See the plans →
From the public news wire
CRON headlines
- Cronos Completes Acquisition of CanAdelaar, Europe’s Largest Adult-Use Cannabis Company
GlobeNewswire Inc. · Oct 15, 2026
- Cronos Group Launches Premium Lord Jones® Brand in Israel, Advancing Borderless Product Strategy
GlobeNewswire Inc. · Feb 2, 2026
- Cronos to enter the Netherlands with acquisition of Europe's largest adult-use cannabis company
Benzinga · Dec 9, 2025
- UPDATE -- Valour Launches Eight New ETPs on Spotlight Stock Market, Including Shiba Inu (SHIB), Pi (PI), Ondo (ONDO), Cronos (CRO), Mantle (MNT), VeChain (VET), Ethena (ENA), and Celestia (TIA)
GlobeNewswire Inc. · Aug 27, 2025
- Cronos Group Inc. to Hold 2025 Second Quarter Earnings Conference Call on August 7, 2025
GlobeNewswire Inc. · Jul 25, 2025
- Cronos Group Inc. Announces Results of 2025 Annual Meeting of Shareholders
GlobeNewswire Inc. · Jun 23, 2025
- Cronos Group Inc. to Hold Virtual 2025 Annual Meeting of Shareholders
GlobeNewswire Inc. · Apr 28, 2025
- Cronos Group Inc. to Hold 2024 Fourth Quarter and Full-Year Earnings Conference Call on February 27, 2025
GlobeNewswire Inc. · Feb 24, 2025
SEC Form 4, most recent first
Insider filings
Martens Christopher
+46.9K
General Manager · Grant or award
· Oct 16, 2026
Garnick Murray R
+48.9K
Director · Grant or award
· Aug 6, 2026
RUDYK JAMES DANIEL
+48.9K
Director · Grant or award
· Aug 6, 2026
ADLER JASON MARC
+48.9K
Director · Grant or award
· Aug 6, 2026
Wagner Adam
+10.4K
See remarks · Option exercise
· May 12, 2026
Kenost Jared Matthew
−9.4K
See Remarks · Option exercise
· May 12, 2026
Kenost Jared Matthew
−3.7K
See Remarks · Shares withheld for tax
$10.18K · May 12, 2026
Doucet Terrence Gregory Joseph
+10.6K
See Remarks · Option exercise
· May 12, 2026
About Cronos Group Inc. Common Share
Cronos Group Inc is a cannabinoid company committed to building disruptive intellectual property by advancing cannabis research, technology, and product development. With a passion for responsibly elevating the consumer experience, the company is building an iconic brand portfolio. Its diverse international brand portfolio includes Spinach, PEACE NATURALS, LIT, and Lord Jones. The company operates in Canada, Israel, and other countries, with the majority of its revenue generated from Canada.
- Exchange
- Nasdaq
- Security
- Common stock
- Industry
- Medicinal Chemicals & Botanical Products
- Headquarters
- Stayner, A6
- Employees
- 610
- Listed since
- Jun 3, 2016
- Website
- thecronosgroup.com
Pick the desk that fits how you trade
Analysis Tools Only for the real-time scanner, Pro Charting and the research desk. Stock Alerts + Tools for the human-reviewed alert feed. Premium Membership for both, at one price.
Try Premium Membership free for 5 days. Card required. After 5 days it is $149 per month or $1,099 per year until you cancel. First-time members only.
Other plans from $39 a month. Pay by card, Apple Pay, Google Pay, Link, Cash App Pay or Amazon Pay through Stripe.